Clinical Trial

Testing Experimental Medication in Healthy Subjects

Study Description

A Study of LY3475766 in Healthy Participants

This three-part study will evaluate the safety and tolerability of LY3475766 when given to participants with high levels of blood fat called triglycerides and to healthy Japanese participants. It will also investigate how the body processes the study drug and the effect of the study drug on the body. Information about any side effects will be documented. This study will last up to 20 weeks for each participant.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - LY3475766 - IV

Administered IV

Drug - LY3475766 - SC

Administered SC

Drug - Placebo - IV

Administered IV

Drug - Placebo - SC

Administered SC

Additional Information

Official Study Title

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3475766

Clinical Trial ID

NCT04052594

ParticipAid ID

bo2rBa